Siren Biotechnology

Siren Biotechnology

Open  for investment

About this raise

Siren Biotechnology, with a valuation of $60 million, is raising funds on Wefunder. The company is focused on fighting cancer with AAV immuno-gene therapy. Siren Biotechnology is merging the precision of gene therapy with the power of immunotherapy to create a universal adeno-associated virus immune-gene therapy that will make cancer treatment scalable, accessible, and effective. The business won the 2025 Startup of The Year award at Phacilitate Advanced Therapies Week and has received $4 million in competitive grant awards from the California Institute for Regenerative Medicine. Dr. Nicole K. Paulk founded Siren Biotechnology in September 2020. The current crowdfunding campaign has a minimum target of $49,995.66 and a maximum target of $4.99 million. The campaign proceeds will be used for non-clinical trials, drug product manufacturing, regulatory preparations, and clinical trial preparation for SRN-101, technological innovations, and operational expenses.

Expand

Investment Overview

Committed this round: $59,928

Deal Terms

Total Commitments

Platform
Wefunder
Start Date
04/10/2025
Close Date
07/09/2025
Min. Goal
$49,996
Max Goal
$4,999,995
Min. Investment

$100

Security Type

Equity - Preferred

Company Stage

Growth Stage

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$6.41

Pre-Money Valuation

$60,000,000

Company & Team

Company

Year Founded
2020
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Location
San Francisco, California
Company Website
Visit Website

Team

Employees
6

Financials

 Revenue
$0
as of FY2024
 Monthly Burn
$388,889
as of FY2024
 Runway
24+ months
as of FY2024

Summary Profit and Loss Statement

FY 2024 FY 2023

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-4,666,672

$-3,659,223

Summary Balance Sheet

FY 2024 FY 2023

Cash

$17,448,263

$2,581,976

Accounts Receivable

$0

$0

Total Assets

$17,539,808

$2,741,295

Short-Term Debt

$784,882

$117,038

Long-Term Debt

$0

$0

Total Liabilities

$784,882

$117,038

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
07/09/2025 Wefunder $60,000,000 $59,928 Equity - Preferred Active RegCF
Create a free account today to gain access to Kingscrowd analytics.
Add to portfolio
Siren Biotechnology on Wefunder 2025
Platform: Wefunder
Security Type: Equity - Preferred
Valuation: $60,000,000
Price per Share: $6.41

Follow company

Follow Siren Biotechnology on Wefunder 2025

Buy Siren Biotechnology's Deal Report

Siren Biotechnology Deal Report

Get Kingscrowd's comprehensive report on Siren Biotechnology including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Siren Biotechnology is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Siren Biotechnology deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge